Aptamer-mediated blockade of IL4Rα triggers apoptosis of MDSCs and limits tumor progression - PubMed (original) (raw)
. 2012 Mar 15;72(6):1373-83.
doi: 10.1158/0008-5472.CAN-11-2772. Epub 2012 Jan 26.
Affiliations
- PMID: 22282665
- DOI: 10.1158/0008-5472.CAN-11-2772
Aptamer-mediated blockade of IL4Rα triggers apoptosis of MDSCs and limits tumor progression
Felix Roth et al. Cancer Res. 2012.
Abstract
In addition to promoting tumor progression and metastasis by enhancing angiogenesis and invasion, myeloid-derived suppressor cells (MDSC) and tumor-associated macrophage (TAM) also inhibit antitumor T-cell functions and limit the efficacy of immunotherapeutic interventions. Despite the importance of these leukocyte populations, a simple method for their specific depletion has not been developed. In this study, we generated an RNA aptamer that blocks the murine or human IL-4 receptor-α (IL4Rα or CD124) that is critical for MDSC suppression function. In tumor-bearing mice, this anti-IL4Rα aptamer preferentially targeted MDSCs and TAM and unexpectedly promoted their elimination, an effect that was associated with an increased number of tumor-infiltrating T cells and a reduction in tumor growth. Mechanistic investigations of aptamer-triggered apoptosis in MDSCs confirmed the importance of IL4Ra-STAT6 pathway activation in MDSC survival. Our findings define a straightforward strategy to deplete MDSCs and TAMs in vivo, and they strengthen the concept that IL4Rα signaling is pivotal for MDSC survival. More broadly, these findings suggest therapeutic strategies based on IL4Rα signaling blockades to arrest an important cellular mechanism of tumoral immune escape mediated by MDSCs and TAM in cancer.
Similar articles
- IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients.
Mandruzzato S, Solito S, Falisi E, Francescato S, Chiarion-Sileni V, Mocellin S, Zanon A, Rossi CR, Nitti D, Bronte V, Zanovello P. Mandruzzato S, et al. J Immunol. 2009 May 15;182(10):6562-8. doi: 10.4049/jimmunol.0803831. J Immunol. 2009. PMID: 19414811 - Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.
Nonaka K, Saio M, Suwa T, Frey AB, Umemura N, Imai H, Ouyang GF, Osada S, Balazs M, Adany R, Kawaguchi Y, Yoshida K, Takami T. Nonaka K, et al. J Leukoc Biol. 2008 Sep;84(3):679-88. doi: 10.1189/jlb.1107729. Epub 2008 Jun 19. J Leukoc Biol. 2008. PMID: 18566103 - Cimetidine suppresses lung tumor growth in mice through proapoptosis of myeloid-derived suppressor cells.
Zheng Y, Xu M, Li X, Jia J, Fan K, Lai G. Zheng Y, et al. Mol Immunol. 2013 May;54(1):74-83. doi: 10.1016/j.molimm.2012.10.035. Epub 2012 Dec 5. Mol Immunol. 2013. PMID: 23220070 - Antigen specificity of immune suppression by myeloid-derived suppressor cells.
Solito S, Bronte V, Mandruzzato S. Solito S, et al. J Leukoc Biol. 2011 Jul;90(1):31-6. doi: 10.1189/jlb.0111021. Epub 2011 Apr 12. J Leukoc Biol. 2011. PMID: 21486906 Review. - Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells.
Marigo I, Dolcetti L, Serafini P, Zanovello P, Bronte V. Marigo I, et al. Immunol Rev. 2008 Apr;222:162-79. doi: 10.1111/j.1600-065X.2008.00602.x. Immunol Rev. 2008. PMID: 18364001 Review.
Cited by
- Tumor-associated macrophages within the immunological milieu: An emerging focal point for therapeutic intervention.
Shao Y, Han S, Hou Z, Yang C, Zhao Y. Shao Y, et al. Heliyon. 2024 Aug 23;10(17):e36839. doi: 10.1016/j.heliyon.2024.e36839. eCollection 2024 Sep 15. Heliyon. 2024. PMID: 39281573 Free PMC article. Review. - Mechanisms of myeloid-derived suppressor cell-mediated immunosuppression in colorectal cancer and related therapies.
Nie SC, Jing YH, Lu L, Ren SS, Ji G, Xu HC. Nie SC, et al. World J Gastrointest Oncol. 2024 May 15;16(5):1690-1704. doi: 10.4251/wjgo.v16.i5.1690. World J Gastrointest Oncol. 2024. PMID: 38764816 Free PMC article. Review. - Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, Recruit.
Kostecki KL, Iida M, Crossman BE, Salgia R, Harari PM, Bruce JY, Wheeler DL. Kostecki KL, et al. Cancers (Basel). 2024 Jan 11;16(2):312. doi: 10.3390/cancers16020312. Cancers (Basel). 2024. PMID: 38254801 Free PMC article. Review. - Aptamers Targeting Membrane Proteins for Sensor and Diagnostic Applications.
Kara N, Ayoub N, Ilgu H, Fotiadis D, Ilgu M. Kara N, et al. Molecules. 2023 Apr 26;28(9):3728. doi: 10.3390/molecules28093728. Molecules. 2023. PMID: 37175137 Free PMC article. Review. - Targeting Tumor Angiogenesis with the Selective VEGFR-3 Inhibitor EVT801 in Combination with Cancer Immunotherapy.
Paillasse MR, Esquerré M, Bertrand FA, Poussereau-Pomié C, Pichery M, Visentin V, Gueguen-Dorbes G, Gaujarengues F, Barron P, Badet G, Briaux A, Ancey PB, Sibrac D, Erdociain E, Özcelik D, Meneyrol J, Martin V, Gomez-Brouchet A, Selves J, Rochaix P, Battistella M, Lebbé C, Delord JP, Dol-Gleizes F, Bono F, Blanc I, Alam A, Hunneyball I, Whittaker M, Fons P. Paillasse MR, et al. Cancer Res Commun. 2022 Nov 29;2(11):1504-1519. doi: 10.1158/2767-9764.CRC-22-0151. eCollection 2022 Nov. Cancer Res Commun. 2022. PMID: 36970050 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous